Barry M. Smith, a director at Ensign Group, Inc. (NASDAQ:ENSG), a healthcare company with a market capitalization of $7.4 billion, has sold 700 shares of common stock, according to a recent SEC filing. The transaction, completed on January 2, 2025, was executed at a price of $133.43 per share, amounting to a total value of $93,401. According to InvestingPro data, the stock generally trades with low price volatility, maintaining a beta of 0.94 over the past five years. After the sale, Smith retains ownership of 30,852 shares in the company. This transaction was conducted under a Rule 10b5-1 trading plan, which was established on July 31, 2024. InvestingPro analysis indicates the company is currently trading at a high earnings multiple with a P/E ratio of 30.7, while maintaining strong revenue growth of 15.5% over the last twelve months. For deeper insights into Ensign Group's valuation and 12 additional ProTips, including detailed financial health metrics, investors can access the comprehensive Pro Research Report available on InvestingPro.
In other recent news, The Ensign Group (NASDAQ:ENSG) has reported a record-setting third-quarter earnings, surpassing expectations with a 15% increase in consolidated revenues, totaling $1.1 billion. Analyst firms UBS, Truist Securities, Stephens, and RBC Capital have responded to these developments with upward revisions of their price targets for The Ensign Group. UBS initiated coverage on the company, recognizing its ability to acquire and revitalize underperforming facilities. Meanwhile, Truist Securities updated its outlook, raising the price target to $170 from the previous $160, citing strong occupancy rates and aggressive merger and acquisition activities.
Stephens has increased the price target for The Ensign Group to $167 from $163, highlighting the company's continued progress and significant year-over-year census growth. RBC Capital maintained an Outperform rating on The Ensign Group and increased the stock's price target to $172 from $167, citing the company's trend-defying occupancy momentum and accelerating merger and acquisition activities.
The Ensign Group's performance was further bolstered by the successful acquisition of 27 new operations, adding 1,279 skilled nursing beds and 20 senior living units. The company remains optimistic about future growth, having raised its 2024 earnings guidance to $5.46 to $5.52 per diluted share. These recent developments underscore The Ensign Group's effective management of market trends and M&A strategies.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.